| Literature DB >> 34156580 |
Rieko Taniguchi1, Hideki Muramatsu2, Yusuke Okuno3, Taro Yoshida1, Manabu Wakamatsu1, Motoharu Hamada1, Chiyoe Shirota4, Wataru Sumida4, Akinari Hinoki5, Takahisa Tainaka4, Yoshimitsu Gotoh6, Toyonori Tsuzuki7, Yukichi Tanaka8, Seiji Kojima1, Hiroo Uchida4, Yoshiyuki Takahashi9.
Abstract
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is caused by heterozygous germline variants in the fumarate hydratase (FH) gene and is associated with increased susceptibility to cutaneous leiomyomas, uterine leiomyomas, and renal cell carcinoma (RCC). HLRCC-associated RCC usually occurs in the middle age, with the median age being 40-44 years. This report describes a seven-year-old (84-month-old) male who developed a large right kidney tumor with multiple cystic lesions that contained enhanced solid components. There was no evidence of distant metastasis. The male patient underwent right nephrectomy and has been recovering well without metastasis or recurrence. Pathological examination revealed that tumor cells with relatively prominent nucleoli and surrounded by halos, were located in a limited area. Immunohistochemical staining was negative for FH. Whole-exome sequencing identified his germline variant in the FH gene and its loss of heterozygosity in the tumor. At nine years (114 months) of age, the male patient showed no recurrence of the tumor. This was the youngest-onset case of HLRCC-associated RCC to date. This report may affect the starting age for future RCC-surveillance programs for patients with HLRCC.Entities:
Keywords: Cystic renal disease; Fumarate hydratase-deficient renal cell carcinoma; HLRCC; Hereditary leiomyomatosis and renal cell cancer
Mesh:
Substances:
Year: 2021 PMID: 34156580 DOI: 10.1007/s10689-021-00268-8
Source DB: PubMed Journal: Fam Cancer ISSN: 1389-9600 Impact factor: 2.446